1. Akebia Therapeutics, Inc. (AKBA)
AKBA
Find the latest Akebia Therapeutics, Inc. (AKBA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
2. Akebia Therapeutics, Inc. (AX9.F) Stock Forum & Discussion
Find the latest Akebia Therapeutics, Inc. (AX9.F) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders ...
Find the latest Akebia Therapeutics, Inc. (AX9.F) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
3. NDAQ:AKBA | Stock Discussion | Akebia Therapeutics Inc - Stockhouse
Get stock insights, analysis and discussion about Akebia Therapeutics Inc (NDAQ:AKBA). Join the AKBA discussion on Canada's largest online investor ...
Get insights, analysis and discussion about Akebia Therapeutics Inc (NDAQ:AKBA) from Canada’s largest online community of active investors.
4. AKBA Conversations From StockTwits - StockNews
Aug 14, 2021 · Get Free Updates. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! ... Information is ...
$AKBAMarket Price - $2.56Average Hold - $3.40Accumulate - Sub $2.45 (raised from $2.30)Price Target - $5Estimated Time Hold - 2QSupport - $2.75, $3.40Floor - $2.09Double Down Target - Sub $2Option - N/AMicro DD - In March, Akebia submitted an NDA to the FDA for vadadustat for the treatment of anemia due to CKD in both adult patients on dialysis and adult patients not on dialysis. In late May, the FDA accepted for filing the NDA for vadadustat for the treatment of anemia due to CKD in both adult patients on dialysis and adult patients not on dialysis. The FDA assigned the application a standard review and a PDUFA target action date of March 29, 2022. Cash, cash equivalents and available-for-sale securities as of June 30, 2021 were $247.0 million .
5. NASDAQ:AKBA - Akebia Therapeutics, Inc. - TradingView
Missing: conversation | Show results with:conversation
View live Akebia Therapeutics, Inc. chart to track its stock's price action. Find market predictions, AKBA financials and market news.
6. Akebia Therapeutics Inc (AKBA) Stock Message Board | InvestorsHub
Apr 17, 2015 · Find the latest Akebia Therapeutics Inc (AKBA) discussion and analysis from iHub's community of investors.
Find the latest Akebia Therapeutics Inc (AKBA) discussion and analysis from iHub's community of investors.
7. AKBA: Akebia Therapeutics Inc - Stock Price, Quote and News - CNBC
Get Akebia Therapeutics Inc (AKBA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
8. AKBA Stock Quote Price and Forecast | CNN
Missing: conversation | Show results with:conversation
View Akebia Therapeutics, Inc. AKBA stock quote prices, financial information, real-time forecasts, and company news from CNN.
9. Akebia Ther (AKBA) Stock Forums - Investing.com
Compiled here, all relevant comments and discussions regarding the AKBA Stock.
10. Foreign Minister Wang Yi Holds Telephone Conversation with His ...
On March 21, 2013, Chinese Foreign Minister Wang Yi exchanged views on bilateral relations with his Iranian counterpart Ali Akba Salehi over the phone.
On March 21, 2013, Chinese Foreign Minister Wang Yi exchanged views on bilateral relations with his Iranian counterpart Ali Akba Salehi over the phone. Lauding the development of bilateral ties, Salehi voiced readiness to maintain communication and contacts with Wang in a bid to jointly promote cooperation in various areas. Wang thanked Salehi for making the phone call. Extending greetings to Salehi on the Iranian New Year, Wang said China treasures its traditional friendship with Iran. China is willing to work with Iran to maintain their healthy relationship and further promote its development so as to benefit the two countries and their people, he said.
11. Akebia Therapeutics Reports Third Quarter 2023 Financial Results and ...
Missing: conversation | Show results with:conversation
/PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney...
12. Rigorous Grace: A Conversation Between Leslie Jamison and Kaveh ...
Sep 30, 2019 · Her writing, like her mind in this conversation, leaps freely between each world. AKBAR. Can we begin by talking about grace? One of the things ...
Leslie Jamison and Kaveh Akbar discuss sobriety, surprise, and breakups.
13. Akebia Therapeutics Inc. - AKBA stock - Biotickr
The biotech company Akebia Therapeutics Inc. trades as AKBA stock on the Nasdaq All ... Log in or sign up to join the conversation. LoginSign up. 0 Comments on ...
The biotech company Akebia Therapeutics Inc. trades as AKBA stock on the Nasdaq All Markets. Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia-inducible factors for patients with kidney disease and other metabolic disorders. Its lead product candidate vadadustat is a HIF-PH inhibitor, a regulator for the production of red blood cells, or RBCs, in the body, as well as other important metabolic functions for the treatment of anemia due to chronic kidney disease (CKD).
14. Akebia Therapeutics (AKBA) Stock Price, News & Info | The Motley Fool
... Discussion Boards · Calculators · Financial Dictionary. Affiliates & Friends. Motley Fool Asset Management · Motley Fool Wealth Management · Motley Fool ...
Real time Akebia Therapeutics (AKBA) stock price quote, stock graph, news & analysis.
15. Akebia Therapeutics Reports First Quarter 2023 Financial Results and ...
Missing: conversation | Show results with:conversation
/PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney...
16. Akebia Therapeutics, Inc. (AKBA) Stock Price, Quote & News
News. All; Videos; PressPress Releases; Conversation. Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4). CAMBRIDGE, Mass. , ...
Get a real-time Akebia Therapeutics, Inc. (AKBA) stock price quote with breaking news, financials, statistics, charts and more.
17. Akebia Therapeutics, Inc. (AKBA) Q2 2023 Earnings Call Transcript
Aug 25, 2023 · ... talking about and expect, then we'll have a conversation with the FDA about supplemental NDA where we'll submit for three times weekly ...
Akebia Therapeutics, Inc. (NASDAQ:NASDAQ:AKBA) Q2 2023 Earnings Conference Call August 25, 2023 9:00 AM ETCompany ParticipantsMercedes Carrasco - Senior...
